CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 47 of 48

Rheumatology (Oxford)

Briefs 1,841–1,880 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud’s

    Randomized controlled trialSystemic sclerosis

  2. Rheumatology (Oxford)

    FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis

    Case-control studySystemic sclerosis

  3. Rheumatology (Oxford)

    PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  4. Rheumatology (Oxford)

    Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease

    Cohort studyMyositis

  5. Rheumatology (Oxford)

    Longitudinal changes in nailfold videocapillaroscopy findings differ by myositis-specific autoantibody in idiopathic inflammatory myopathy

    Cohort studyMyositis

  6. Rheumatology (Oxford)

    COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study

    Cohort studyLupus & APS

  7. Rheumatology (Oxford)

    Work situation, work ability and expectation of returning to work in patients with systemic autoimmune myopathies

    Cross-sectional studyMyositis

  8. Rheumatology (Oxford)

    Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis

    Case-control studyVasculitis & PMR

  9. Rheumatology (Oxford)

    Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization

    Cross-sectional studySpondyloarthritis & PsA

  10. Rheumatology (Oxford)

    Autologous stem cell transplantation improves cardiopulmonary exercise testing outcomes in systemic sclerosis patients

    Cohort studySystemic sclerosis

  11. Rheumatology (Oxford)

    Characteristics and outcomes of a Hispanic lupus nephritis cohort from Mexico

    Cohort studyLupus & APS

  12. Rheumatology (Oxford)

    Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis

    Cross-sectional studyVasculitis & PMR

  13. Rheumatology (Oxford)

    Serum cholesterol loading capacity of macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients

    Cross-sectional studyRA

  14. Rheumatology (Oxford)

    Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1

    Secondary analysisSpondyloarthritis & PsA

  15. Rheumatology (Oxford)

    Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis

    Mechanistic studySpondyloarthritis & PsA

  16. Rheumatology (Oxford)

    Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE

    Randomized controlled trialSpondyloarthritis & PsA

  17. Rheumatology (Oxford)

    Long-term cardiovascular outcomes and temporal trends in patients diagnosed with ANCA-associated vasculitis: a Danish nationwide registry study

    Cohort studyVasculitis & PMR

  18. Rheumatology (Oxford)

    Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors

    Cohort studyPediatric

  19. Rheumatology (Oxford)

    Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation

    Diagnostic or prognostic studySpondyloarthritis & PsA

  20. Rheumatology (Oxford)

    Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis

    Meta-analysisSpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies

    Cross-sectional studyMyositis

  22. Rheumatology (Oxford)

    Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

    Cohort studyLupus & APS

  23. Rheumatology (Oxford)

    Genetic contributions to female gout and hyperuricaemia using genome-wide association study and polygenic risk score analyses

    Diagnostic or prognostic studyGout & crystals

  24. Rheumatology (Oxford)

    Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis

    Cohort studyVasculitis & PMR

  25. Rheumatology (Oxford)

    Upregulated expression of FFAR2 and SOC3 genes is associated with gout

    Cross-sectional studyGout & crystals

  26. Rheumatology (Oxford)

    Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies

    Diagnostic or prognostic studyMyositis

  27. Rheumatology (Oxford)

    Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort

    Cohort studySystemic sclerosis

  28. Rheumatology (Oxford)

    Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

    Cohort studySpondyloarthritis & PsA

  29. Rheumatology (Oxford)

    Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out

    Diagnostic or prognostic studyPediatric

  30. Rheumatology (Oxford)

    TOX promotes follicular helper T cell differentiation in patients with primary Sjögren’s syndrome

    Mechanistic studySjögren's & overlap

  31. Rheumatology (Oxford)

    Use of primary health care and radiological imaging preceding a diagnosis of rheumatoid arthritis: a nationwide cohort study in Denmark

    Cohort studyRA

  32. Rheumatology (Oxford)

    Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort

    Cohort studySystemic sclerosis

  33. Rheumatology (Oxford)

    Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease

    Cohort studySystemic sclerosis

  34. Rheumatology (Oxford)

    Behçet syndrome in children and adults: discovering similarities and differences by a comparative study

    Cohort studyPediatric

  35. Rheumatology (Oxford)

    Circulating and renal fibrocytes are associated with interstitial fibrosis in lupus nephritis

    Mechanistic studyLupus & APS

  36. Rheumatology (Oxford)

    Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry

    Cohort studyPediatric

  37. Rheumatology (Oxford)

    Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography

    Cross-sectional studySpondyloarthritis & PsA

  38. Rheumatology (Oxford)

    Resting state functional connectivity in SLE patients and association with cognitive impairment and blood–brain barrier permeability

    Cross-sectional studyLupus & APS

  39. Rheumatology (Oxford)

    Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality

    Cohort studyVasculitis & PMR

  40. Rheumatology (Oxford)

    Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren’s syndrome: the impact of BAFF genetic variations

    Cross-sectional studyRA

All 1,905 Briefs in ExploreShowing Briefs 1,841–1,880 of 1,905, newest first